Sara Louati
Overview
Explore the profile of Sara Louati including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ettoury S, Louati S, Saad I, Bentayebi K, Zarrik O, Bourkadi J, et al.
Expert Opin Drug Metab Toxicol
. 2024 Nov;
21(2):191-201.
PMID: 39501971
Introduction: Adverse drug reactions (ADRs) pose a significant challenge in clinical practice, impacting patient safety and treatment outcomes. Genetic variations in drug-metabolizing enzymes, particularly glutathione S-transferases (GSTs), have been implicated...
2.
Senhaji N, Squalli Houssaini A, Lamrabet S, Louati S, Bennis S
Int J Mol Sci
. 2022 Jul;
23(13).
PMID: 35806478
Glioblastoma is the most aggressive malignant tumor of the central nervous system with a low survival rate. The difficulty of obtaining this tumor material represents a major limitation, making the...
3.
Louati S, Senhaji N, Chbani L, Bennis S
Dis Markers
. 2018 Oct;
2018:7971019.
PMID: 30319719
Ewing sarcoma/primitive neuroectodermal tumor (Ewing/PNET sarcomas or EPS) are a group of round cell tumors. Malignant round cell tumors form a large and diverse group that includes rhabdomyosarcoma, synovial sarcoma,...
4.
Senhaji N, Louati S, Chbani L, El Fatemi H, Hammas N, Mikou K, et al.
Biomed Res Int
. 2017 Aug;
2017:8045859.
PMID: 28785587
Glioblastomas are the most frequent and aggressive primary brain tumors which are expressing various evolutions, aggressiveness, and prognosis. Thus, the 2007 World Health Organization classification based solely on the histological...
5.
Senhaji N, Louati S, Chbani L, El Bardai S, Mikou K, Maaroufi M, et al.
Asian Pac J Cancer Prev
. 2016 Jun;
17(5):2649-53.
PMID: 27268645
Background: Genetic alterations in gliomas have increasing importance for classification purposes. Thus, we are especially interested in studying IDH mutations which may feature potential roles in diagnosis, prognosis and response...